Theuer explains despite engaging in five different clinical trials, three of the five company's clinical trials are funded by its partners, allowing it to have a 1 year cash runway into 2020.
Full interview: TRACON Pharmaceuticals reveals its low-cost drug development efforts in its 4Q and FY results
Quick facts: TRACON Pharmaceuticals
Price: 2.3 USD
Market Cap: $12.65 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of TRACON Pharmaceuticals named herein, including the promotion by the Company of TRACON Pharmaceuticals in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE